SCA27B study aims to map disease progression in 300 participants
NCT ID NCT06472557
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 300 people with a rare genetic movement disorder called SCA27B, along with some family members and healthy volunteers, for up to 2 years. Researchers will use exams, digital devices, and blood tests to measure how the disease changes over time. The goal is to find the best ways to track the disease in future treatment trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINOCEREBELLAR ATAXIA TYPE 27B are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Center for Neurology & Hertie-Institute for Clinical Brain Research, Dept. for Neurodegenerative Diseases
RECRUITINGTübingen, Baden-Wurttemberg, 72076, Germany
-
Department of Neurology & Center for Translational Neuro- and Behavioral Sciences, Essen University Hospital, University of Duisburg-Essen
RECRUITINGEssen, North Rhine-Westphalia, 45147, Germany
-
Department of Neurology, Donostia University Hospital, BioGipuzkoa Health Research Institute
RECRUITINGSan Sebastián, Gipuzkoa, 20014, Spain
-
Department of Neurology, Motol University Hospital, Second Faculty of Medicine, Charles University
RECRUITINGPrague, 15006, Czechia
-
IRCCS Fondazione Stella Maris
RECRUITINGPisa, 56128, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.